Clinical trials
Phase 3 Carcinoma, Hepatocellular trials in the Philippines
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Imunon | 2 |
| Eisai Limited | 1 |
| Eli Lilly and Company | 1 |
| Exelixis | 1 |
| Light Sciences Oncology | 1 |
| National Medical Research Council (NMRC), Singapore | 1 |
| Pfizer | 1 |
| Singapore General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 11 |
| Liver Neoplasms | 6 |
| Neoplasms | 3 |
| Carcinoma | 2 |
| Adenocarcinoma | 1 |
| Digestive System Diseases | 1 |
| Digestive System Neoplasms | 1 |
| Liver Diseases | 1 |
| Neoplasms by Histologic Type | 1 |
| Neoplasms by Site | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.